✦ LIBER ✦

A phase II study of chronic low dose of interleukin-2 (IL-2) and α-interferon (IFN-α) in Metastatic Renal Cell Carcinoma (MRCC)

✍ Scribed by Michele Potenzoni; Luigi Benecchi; Nicoletta Uliano; Federico Cantoni; Matteo Dalla Chiesa; Rita Cengarle; Rodolfo Passalacqua; Carlo Buzio; Laura Pavone; Domenico Potenzoni

Book ID: 118643798
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 202 KB
Volume: 1
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(02)80420-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LOW-DOSE INTERLEUKIN-2 (IL-2) IN COMBINA

LOW-DOSE INTERLEUKIN-2 (IL-2) IN COMBINATION WITH INTERFERON-A (IFN) AND 5-FLUOROURACIL (5-FU) FOR METASTATIC RENAL CELL CARCINOMA (MRCC)

✍ Kharkevich, G.; Tsimafeyeu, I.; Demidov, L. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB

388 - Interleukin-2 (IL-2). Interferon-α

388 - Interleukin-2 (IL-2). Interferon-α (IFN-α), 5-fluorouracil (5-FU) and vinblastine (VBL) for metastatic renal cell carcinoma (MRCC): A clinical and immunological study

✍ E. Gez; R. Rubinov; T. Mekori; L. Struminger; R. Skigin; S. Keren; N. Haim; A. K 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 262 KB

A phase II study of interferon α and low

A phase II study of interferon α and low-dose subcutaneous interleukin-2 in advanced renal cell carcinoma

✍ A. Piga; Paolo Giordani; Agata Quattrone; Marco Giulioni; Giorgio De Signoribus; 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 72 KB

Interleukin-2 (IL-2) and alpha-2 Interfe

Interleukin-2 (IL-2) and alpha-2 Interferon in metastatic renal cell carcinoma (MRCC): Analysis of 22 cases

✍ Landatio, G.; Baiocchi, C.; Cattaneo, D.; Majno, M.; Scanzi, F.; Rassu, G. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Interleukin-2 (IL-2), interferon-A (IFN-

Interleukin-2 (IL-2), interferon-A (IFN-A), 5-fluorouracil (5-FU) and vinblastine (VBL) for treatment of metastatic renal cell carcinoma (MRCC)

✍ E. Gez; R. Rubinov; D. Gaitini; S. Meritick; L. Best; O. Native; A. Stein; J. Zi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 189 KB

150 - Subcutaneous (SC) interleukin-2 (I

150 - Subcutaneous (SC) interleukin-2 (IL-2) plus alpha interferon (IFN-α) and 5 fluorouracil (5 FU) in out-patients (pts) with metastatic renal cell carcinoma (MRCC). Scapp II trial

✍ J.M. Tourani; A. Benhammouda; P. Guillet; C. Pfister; B. Paule; J.F. Berbah; Y. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 262 KB